Wedmont Private Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Wedmont Private Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Buy	6,723 +159	+2%	+$12K	0.01%	645
2026 Q1	$492K	Buy	6,564 +1,028	+19%	+$81.1K	0.02%	497
2025 Q4	$460K	Buy	5,536 +173	+3%	+$13K	0.02%	507
2025 Q3	$370K	Buy	5,363 +81	+2%	+$3.96K	0.01%	556
2025 Q2	$226K	Buy	+5,282	New	+$173K	0.01%	685

Other funds holding IONS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wedmont Private Capital's IONS Position: Q2 2026 in Review

Wedmont Private Capital increased its Ionis Pharmaceuticals (IONS) stake by 2.4% in Q2 2026, buying an estimated $12K and bringing the position to 6,723 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #645.

Wedmont Private Capital first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. The position peaked at $492K in Q1 2026. 218 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Wedmont Private Capital held 6,723 shares of Ionis Pharmaceuticals worth $392K as of Q2 2026.
Wedmont Private Capital bought 159 Ionis Pharmaceuticals shares in Q2 2026, an estimated $12K.
Ionis Pharmaceuticals made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #645 holding.
Wedmont Private Capital first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
Wedmont Private Capital's Ionis Pharmaceuticals position peaked at $492K in Q1 2026.
218 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.